Asthma is a chronic inflammatory airway disease with variable airflow obstruction, bronchial hyperresponsiveness, and episodes of wheezing, coughing, chest tightness, and dyspnea. This module focuses on RT-level recognition, assessment, acute management, long-term control, peak flow interpretation, and escalation during status asthmaticus.
By the end of this asthma module, learners should be able to connect airway inflammation, bronchospasm, mucus production, clinical findings, diagnostic data, treatment decisions, and escalation priorities.
Watch this quick overview before moving into the disease snapshot.
Asthma is an obstructive airway disease, but unlike COPD, the obstruction is typically variable and often reversible. During an exacerbation, narrowed airways make exhalation difficult, causing air trapping, increased work of breathing, and possible ventilatory failure if the patient becomes fatigued.
For RTs, asthma is not simply wheezing. It is a dynamic airflow problem. The RT must decide whether the patient is moving air effectively, responding to bronchodilator therapy, tiring out, or progressing toward respiratory failure.
Immediately associate asthma with reversible obstruction, decreased FEV₁/FVC, triggers, SABA rescue therapy, inhaled corticosteroid control therapy, peak flow zones, and rising PaCO₂ as a late/danger sign during severe exacerbation.
Which statement best describes the core airflow problem in asthma?
Asthma involves airway inflammation, smooth muscle constriction, mucus production, and bronchial hyperresponsiveness. These changes narrow the airway lumen and increase airflow resistance, especially during exhalation.
| Asthma Change | What Happens | Why It Matters |
|---|---|---|
| Airway inflammation | Airway lining becomes swollen and irritated. | Narrows the airway and increases resistance. |
| Bronchospasm | Airway smooth muscle constricts. | Creates acute airflow obstruction and wheezing. |
| Mucus production | Secretions become thicker and more difficult to clear. | Can plug smaller airways and worsen ventilation. |
| Air trapping | Exhalation becomes incomplete. | Increases WOB and can lead to fatigue. |
| V/Q mismatch | Some regions are perfused but poorly ventilated. | Can cause hypoxemia. |
Early in an asthma exacerbation, the patient often hyperventilates and may have a low PaCO₂. If the patient becomes fatigued, PaCO₂ may normalize or rise. A rising PaCO₂ in a patient who is still in distress is a red flag for ventilatory failure.
A patient who was wheezing loudly but suddenly becomes very quiet may not be improving. A silent chest can mean air movement is severely reduced.
Click each hotspot to reveal how that structure contributes to asthma.
Asthma symptoms often occur after exposure to triggers that irritate or inflame hyperresponsive airways. Triggers vary by patient and may include allergens, exercise, cold air, respiratory infection, smoke, occupational exposures, strong odors, stress, and medication sensitivity.
| Trigger or Risk Factor | Why It Matters | Teaching Focus |
|---|---|---|
| Allergens | Can activate inflammatory pathways. | Identify and reduce exposure when possible. |
| Exercise | Can trigger bronchospasm in susceptible patients. | Plan pretreatment/action plan when ordered. |
| Cold air | Can irritate hyperresponsive airways. | Use avoidance and protection strategies. |
| Viral infection | Common exacerbation trigger. | Monitor worsening symptoms and rescue use. |
| Smoke/strong odors | Direct airway irritants. | Remove exposure and educate. |
| Aspirin/NSAID sensitivity | Can worsen symptoms in sensitive patients. | Review medication history. |
Choose the best category for each item, then check your answers.
Asthma presentation ranges from mild cough or wheeze to severe respiratory distress. RT assessment should focus on air movement, work of breathing, oxygenation, ventilation, speech pattern, mental status, and response to treatment.
| Finding Type | What the RT May See |
|---|---|
| Symptoms | Wheezing, cough, dyspnea, chest tightness, nocturnal symptoms, exercise limitation. |
| Appearance | Anxiety, tripod position, accessory muscle use, inability to speak full sentences. |
| Breath sounds | Wheezing, diminished breath sounds, prolonged expiratory phase, silent chest in severe obstruction. |
| Oxygenation clues | Low SpO₂, low PaO₂, cyanosis in severe cases. |
| Ventilation clues | Low PaCO₂ early; normalizing/rising PaCO₂ as fatigue develops. |
| Response clues | Improvement in WOB, air movement, peak flow, and symptoms after bronchodilator therapy. |
A severe asthma patient who becomes drowsy, quiet, or less responsive is more concerning than a patient who is loudly wheezing but still moving air. Quiet can mean failure.
Diagnostic data helps confirm reversible obstruction, monitor exacerbation severity, identify poor response, and rule out alternate causes of dyspnea.
| Finding | Asthma Pattern |
|---|---|
| FEV₁ | Decreased during obstruction; improves with bronchodilator when reversible. |
| FVC | Normal or decreased during air trapping. |
| FEV₁/FVC | Decreased during obstruction. |
| Bronchodilator response | Significant improvement supports asthma. |
| Peak expiratory flow | Useful for monitoring severity and action plan zones. |
| Pattern | Meaning |
|---|---|
| Low PaCO₂ with respiratory distress | Often early hyperventilation. |
| Normal PaCO₂ despite severe distress | Concerning because PaCO₂ may be rising from prior low level. |
| High PaCO₂ with fatigue or altered mental status | Possible ventilatory failure. |
| Low PaO₂ | Hypoxemia from V/Q mismatch or severe obstruction. |
Chest x-ray may show hyperinflation during an exacerbation, but it is also useful for ruling out pneumonia, pneumothorax, or other causes of respiratory distress.
Asthma severity considers symptom frequency, nighttime awakenings, rescue medication use, activity limitation, lung function, and exacerbation history. Peak flow zones help translate the patient’s personal best into action levels.
| Severity Category | Typical Pattern |
|---|---|
| Intermittent | Symptoms ≤2 days/week; nighttime symptoms ≤2 times/month; normal lung function between episodes. |
| Mild persistent | Symptoms >2 days/week but not daily; minor limitation may occur. |
| Moderate persistent | Daily symptoms; nighttime symptoms more than once per week; some activity limitation. |
| Severe persistent | Symptoms throughout the day; frequent nighttime symptoms; extreme activity limitation. |
A patient’s personal best peak flow is 500 L/min. Today’s peak flow is 225 L/min. Which zone is this?
The key question is not simply “Does this patient have asthma?” The key question is whether the patient is moving enough air to maintain ventilation.
| Red Flag | Why It Matters |
|---|---|
| Silent chest or very poor air movement | May indicate severe obstruction and impending failure. |
| Rising PaCO₂ with distress | Suggests fatigue and worsening ventilation. |
| New confusion, drowsiness, or exhaustion | May indicate hypoxemia, hypercapnia, or respiratory muscle fatigue. |
| Inability to speak full sentences | Significant respiratory distress. |
| Peak flow below 50% personal best | Red zone; severe obstruction risk. |
| No improvement after initial bronchodilator therapy | Treatment failure; reassess and escalate. |
Asthma management depends on whether the patient is stable, acutely symptomatic, or progressing toward respiratory failure. Rescue therapy treats acute bronchospasm. Controller therapy treats chronic inflammation.
| Class | Example | Why It Helps |
|---|---|---|
| SABA | Albuterol | Rapid bronchodilation for acute symptoms. |
| ICS | Fluticasone, budesonide | Reduces chronic airway inflammation. |
| LABA | Salmeterol, formoterol | Long-acting bronchodilation; used with ICS for asthma control, not alone. |
| Anticholinergic | Ipratropium | Added in moderate/severe acute exacerbations. |
| Systemic steroid | Prednisone, methylprednisolone | Reduces inflammation during significant exacerbation; not immediate bronchodilation. |
| Magnesium sulfate | IV magnesium | May be used for severe exacerbations with poor initial response. |
Increase therapy when asthma is uncontrolled, and step down only after sustained control. Long-term plans typically increase anti-inflammatory/controller support as symptom burden and exacerbation risk increase.
Select the steps in the best general order for a moderate to severe asthma exacerbation.
Status asthmaticus is a severe asthma exacerbation that does not respond adequately to standard initial treatment. These patients are at risk for respiratory failure.
In severe asthma requiring ventilation, avoid breath stacking. Concepts usually include lower respiratory rate, longer expiratory time, careful monitoring for auto-PEEP, and permissive hypercapnia when clinically appropriate and ordered.
The RT is central to asthma assessment, treatment delivery, monitoring, education, and escalation. The RT should assess respiratory rate and pattern, work of breathing, breath sounds, peak flow, oxygen device/settings, SpO₂, mental status, triggers, baseline status, and response to therapy.
| RT Task | What to Assess or Do | Why It Matters |
|---|---|---|
| Assess ventilation | RR, pattern, PaCO₂ trend, mental status, fatigue. | Detects impending ventilatory failure. |
| Assess oxygenation | SpO₂, PaO₂, cyanosis, oxygen need. | Identifies hypoxemia and response. |
| Evaluate breath sounds | Wheezes, diminished sounds, silent chest. | Guides therapy and escalation. |
| Monitor response | Pre/post bronchodilator symptoms, air movement, peak flow. | Determines effectiveness. |
| Educate patient | Inhaler technique, spacer use, triggers, peak flow/action plan. | Supports long-term control. |
This guided case reveals one clinical stage at a time. Learners make an RT decision, receive feedback, and then continue to the next stage.
A 19-year-old patient arrives with shortness of breath after exposure to a cat. They are anxious, wheezing, and speaking in short phrases.
Decision Question: What is the priority first action?
After initial albuterol treatments, the patient remains dyspneic. Wheezing is still present, RR is 32/min, and accessory muscles are visible.
Decision Question: Which additional therapy is commonly added for moderate to severe exacerbation?
The patient’s ABG initially shows pH 7.48, PaCO₂ 30 mm Hg, PaO₂ 64 mm Hg. Later, they become fatigued and PaCO₂ rises to 48 mm Hg.
Decision Question: How should the rising PaCO₂ be interpreted?
The patient becomes drowsy. Breath sounds are very diminished. The team prepares for possible intubation and mechanical ventilation.
Decision Question: Which ventilator strategy concept is most important in severe asthma?
Answer each question to complete this activity. Answer choices shuffle each time the lesson opens.
A patient with asthma has wheezing, dyspnea, and a decreased FEV₁/FVC ratio that improves significantly after bronchodilator administration. What does this support?
Which finding is most concerning in a severe asthma exacerbation?
Which medication class is the foundation of long-term inflammation control in persistent asthma?
In status asthmaticus requiring ventilation, which approach helps reduce dynamic hyperinflation?
Asthma is a chronic inflammatory airway disease where triggers can cause bronchospasm, swelling, mucus, and reversible airflow obstruction.
Asthma is often episodic, trigger-driven, and more reversible. COPD is usually progressive and less fully reversible.
Early asthma often causes hyperventilation and low PaCO₂. If PaCO₂ normalizes or rises while distress continues, the patient may be fatiguing and failing to ventilate.
No. Wheezing requires airflow. A severe patient with very diminished or absent breath sounds may be worse than a loud wheezer.
Peak flow estimates how quickly the patient can exhale. It helps monitor severity and action plan zones compared with personal best.
LABA should not be used as sole asthma control therapy. It is typically paired with inhaled corticosteroid therapy when indicated.
Status asthmaticus is a severe asthma exacerbation that does not respond adequately to standard initial treatment and may progress to respiratory failure.
Asthma is a chronic inflammatory obstructive airway disease with variable and often reversible airflow obstruction. Acute symptoms occur when triggers cause bronchospasm, mucus, and airway swelling. Severe asthma can progress to air trapping, fatigue, rising PaCO₂, and respiratory failure.
Terms are stored once and can power inline tooltips, glossary entries, and flashcards.
Click the card to flip it. Use Term → Definition or Definition → Term mode. Mark known cards to move them into the completed pile.